Positive.

From Yahoo Finance: 2025-05-23 07:21:00

Jim Cramer discussed Medtronic plc (MDT) on Mad Money, praising the medical device powerhouse but cautioning about its inconsistent stock performance. With 67 hedge fund holders, MDT forecasts organic revenue growth of 4.75%-5% in fiscal year 2025 and diluted non-GAAP EPS between $5.44-$5.50. Ranked 11th on Cramer’s radar, MDT faces competition from AI stocks with higher potential.

Read more: “I Like This Medical Device Powerhouse”